Literature DB >> 7420272

Compartment- and model-independent linear plateau principle of drugs during a constant-rate absorption or intravenous infusion.

W L Chiou.   

Abstract

A simple general equation is derived to show the linear plateau principle under various conditions during or after a constant or changing rate of absorption or intravenous infusion. The time required to cause a certain fraction (ft) of the total shift or change between the two steady-state plasma concentrations is equal to the time required for the cumulative (from time zero) plasma area, AUC 0 leads to t, to reach the same fracton of AUC 0 leads to infinity assumed to be obtained after an instantaneous intravenous dosing. The role of the terminal biological half-life and the importance of the early distribution phase and its exponential half-life or lives in the plateau principle are discussed. Clinical implications and applications to multiple dosage regimens are also discussed.

Mesh:

Substances:

Year:  1980        PMID: 7420272     DOI: 10.1007/bf01059648

Source DB:  PubMed          Journal:  J Pharmacokinet Biopharm        ISSN: 0090-466X


  15 in total

1.  Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.

Authors:  J G Wagner
Journal:  J Pharmacokinet Biopharm       Date:  1976-10

2.  A simple equation to estimate the fraction of drug remaining in the body after an intravenous injection.

Authors:  W L Chiou
Journal:  J Pharm Pharmacol       Date:  1972-04       Impact factor: 3.765

3.  Shortcomings in pharmacokinetic analysis by conceiving the body to exhibit properties of a single compartment.

Authors:  S Riegelman; J C Loo; M Rowland
Journal:  J Pharm Sci       Date:  1968-01       Impact factor: 3.534

4.  Rapid compartment- and model-independent estimation of times required to attain various fractions of steady-state plasma level during multiple dosing of drugs obeying superposition principle and having various absorption or infusion kinetics.

Authors:  W L Chiou
Journal:  J Pharm Sci       Date:  1979-12       Impact factor: 3.534

5.  Commentary. Drug distribution and pharmacologic effects.

Authors:  M Gibaldi; G Levy; H Weintraub
Journal:  Clin Pharmacol Ther       Date:  1971 Sep-Oct       Impact factor: 6.875

6.  Midpoint back-extrapolation method for the rapid estimation of drugs' volume of distribution and dosage adjustment exhibiting multicompartmental characteristics.

Authors:  W L Chiou; S M Huang; Y C Huang
Journal:  Int J Clin Pharmacol Ther Toxicol       Date:  1980-01

7.  Critical evaluation of the potential error in pharmacokinetic studies of using the linear trapezoidal rule method for the calculation of the area under the plasma level--time curve.

Authors:  W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1978-12

8.  Fluorocarbon aerosol propellants X: pharmacokinetics of dichlorotetrafluoroethane in dogs.

Authors:  S Niazi; W L Chiou
Journal:  J Pharm Sci       Date:  1976-01       Impact factor: 3.534

9.  Pharmocokinetics of hexobarbital in man after intravenous infusion.

Authors:  D D Breimer; C Honhoff; W Zilly; E Richter; J M van Rossum
Journal:  J Pharmacokinet Biopharm       Date:  1975-02

10.  Pharmacokinetics/pharmacodynamics of furosemide in man: a review.

Authors:  L Z Benet
Journal:  J Pharmacokinet Biopharm       Date:  1979-02
View more
  10 in total

1.  Predicting the time needed to achieve steady state if absorption and elimination constants are equal.

Authors:  J Singer; L Vereczkey
Journal:  J Pharmacokinet Biopharm       Date:  1999-06

Review 2.  The phenomenon and rationale of marked dependence of drug concentration on blood sampling site. Implications in pharmacokinetics, pharmacodynamics, toxicology and therapeutics (Part II).

Authors:  W L Chiou
Journal:  Clin Pharmacokinet       Date:  1989-10       Impact factor: 6.447

3.  Similarity or discrepancy in pharmacokinetic parameter estimation between bolus and infusion studies.

Authors:  W L Chiou; S M Chung; G Robbie
Journal:  J Pharmacokinet Biopharm       Date:  1997-08

4.  Simple approximate formulas for calculating the time to clear drug and the time to accumulate drug when the plasma disposition curve of the drug is multiexponential.

Authors:  D A Noe
Journal:  J Pharmacokinet Biopharm       Date:  1994-12

5.  Model-independent assessment of accumulation kinetics based on moments of drug disposition curves.

Authors:  M Weiss
Journal:  Eur J Clin Pharmacol       Date:  1984       Impact factor: 2.953

6.  Accumulation profiles during quasi-uniform multiple dosing regimens.

Authors:  I A Nestorov
Journal:  J Pharmacokinet Biopharm       Date:  1993-08

7.  Elucidation of human amphotericin B pharmacokinetics: identification of a new potential factor affecting interspecies pharmacokinetic scaling.

Authors:  G Robbie; W L Chiou
Journal:  Pharm Res       Date:  1998-10       Impact factor: 4.200

8.  Effects of the rate and composition of fluid replacement on the pharmacokinetics and pharmacodynamics of intravenous furosemide.

Authors:  T Li; M G Lee; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1986-10

9.  Pharmacokinetics and tissue distribution of chlorpheniramine in rabbits after intravenous administration.

Authors:  S M Huang; W L Chiou
Journal:  J Pharmacokinet Biopharm       Date:  1981-12

10.  Proposal for defining the relevance of drug accumulation derived from single dose study data for modified release dosage forms.

Authors:  Christian Scheerans; Roland Heinig; Wolfgang Mueck
Journal:  Biopharm Drug Dispos       Date:  2015-01-21       Impact factor: 1.627

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.